Warren E. Barnes - Feb 28, 2022 Form 4 Insider Report for HANOVER INSURANCE GROUP, INC. (THG)

Signature
/s/ Matthew R. Frascella pursuant to Confirming Statement
Stock symbol
THG
Transactions as of
Feb 28, 2022
Transactions value $
-$87,228
Form type
4
Date filed
3/2/2022, 03:05 PM
Previous filing
Jan 4, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THG Common Stock Options Exercise $138K +1.17K +28.49% $117.22 5.29K Feb 28, 2022 Direct
transaction THG Common Stock Sale -$164K -1.17K -22.17% $140.00 4.12K Feb 28, 2022 Direct
transaction THG Common Stock Options Exercise $239K +2.02K +49% $118.54 6.14K Feb 28, 2022 Direct
transaction THG Common Stock Sale -$283K -2.02K -32.88% $140.00 4.12K Feb 28, 2022 Direct
transaction THG Common Stock Options Exercise $80.3K +696 +16.89% $115.35 4.82K Feb 28, 2022 Direct
transaction THG Common Stock Sale -$97.4K -696 -14.45% $140.00 4.12K Feb 28, 2022 Direct
transaction THG Common Stock Award $0 +209 +5.07% $0.00 4.33K Feb 28, 2022 Direct F1
transaction THG Common Stock Award $0 +118 +2.73% $0.00 4.45K Feb 28, 2022 Direct F2
transaction THG Common Stock Award $0 +628 +14.12% $0.00 5.08K Feb 28, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THG Common Stock Option (right to buy) Options Exercise $0 -1.17K -66.7% $0.00 586 Feb 28, 2022 Common Stock 1.17K $117.22 Direct F4
transaction THG Common Stock Option (right to buy) Options Exercise $0 -2.02K -66.66% $0.00 1.01K Feb 28, 2022 Common Stock 2.02K $118.54 Direct F5
transaction THG Common Stock Option (right to buy) Options Exercise $0 -696 -33.33% $0.00 1.39K Feb 28, 2022 Common Stock 696 $115.35 Direct F6
transaction THG Common Stock Option (right to buy) Award $0 +1.53K $0.00 1.53K Feb 28, 2022 Common Stock 1.53K $139.51 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 5, 2019, the Reporting Person was granted 184 (target) performance-based restricted stock units ("PBRSUs") pursuant to the Issuer's 2014 Long-Term Incentive Plan. These PBRSUs were subject to a performance-based vesting condition related to three-year average adjusted return on equity and a time-based vesting condition and also provided for the accumulation of dividend equivalent rights. On February 28, 2022, the performance condition for this award was certified at 146.4% of the target award (as adjusted for accumulated dividend equivalent rights) for the number of shares indicated. This award remains subject to the time-based vesting condition and is scheduled to vest on March 7, 2022.
F2 On March 5, 2019, the Reporting Person was granted 202 (target) PBRSUs pursuant to the Issuer's 2014 Long-Term Incentive Plan. These PBRSUs were subject to a performance-based vesting condition related to three-year relative total shareholder return and a time-based vesting condition and also provided for the accumulation of dividend equivalent rights. On February 28, 2022, the performance condition for this award was certified at 91.67% of the target award (as adjusted for accumulated dividend equivalent rights) for the number of shares indicated. This award remains subject to the time-based vesting condition and is scheduled to vest on March 7, 2022.
F3 Grant of restricted stock units under the Issuer's 2014 Long-Term Incentive Plan. Such units vest on the third anniversary of the date of grant.
F4 The option, representing the right to purchase a total of 1,760 shares, vested 1/3 each on of March 5, 2020 and March 5, 2021, and the remaining 1/3 shall vest on March 5, 2022.
F5 The option, representing the right to purchase a total of 3,029 shares, vested 1/3 each on February 28, 2021 and February 28, 2022, and the remaining 1/3 shall vest on February 28, 2023.
F6 The option, representing the right to purchase a total of 2,088 shares, vested 1/3 on February 26, 2022, and 1/3 shall vest on each of February 26, 2023 and February 26, 2024.
F7 Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.